Screening agents, screening kits, and screening methods for screening at least one agent selected from the group consisting of agents for increasing or reducing the number of cells of frizzled 3 expressing cells, diabetes prevention or treatment agents, insulinoma prevention or treatment agents, and insulin secretion promoters or inhibitors
JP2020027052A
Method for aiding determination of affection possibility of gynecology disease, method for collecting data to diagnose affection possibility of gynecology disease, and diagnostic kit of gynecology disease
JP2019198271A
Use of double-stranded nucleic acid molecules, dna, vectors, cancer cell growth inhibitors, medicines, and spon1-trim29 fusion genes
JP2019190883A
New lung cancer marker
JP2019149987A
Method for predicting the effectiveness of radiotherapy to head and neck squamous cell carcinoma
KR20190112027A
Immune Biomarkers for Predicting Clinical Effects of Cancer Immunotherapy
JP2019045540A
Image processing device, image processing method, and image processing program
EP3474001A1
Test object visualizing device
JP2018175579A
Ankle hemodynamics index calculation device, ankle hemodynamics index calculation method, ankle hemodynamics index calculation program, and blood pressure measuring device
JP2018067203A
Danger notification device, danger notification method, and calibration method for danger notification device
JP2018038466A
Method for evaluating therapeutic effect by medicine in cancer patient, method for creating evaluation data on therapeutic effect, evaluation device for therapeutic effect, and evaluation program for therapeutic effect
JP2018008915A
Thickening agent, composition kit, and method for thickening composition
JP2017217037A
Applicator for uterine cancer intracavitary irradiation, radiation treatment planning method of uterine cancer and radiation treatment planning device of uterine cancer